GLP-1 acts through a class 2 member of the G-coupled protein C receptor family seven-transmembrane receptor (GLP-1R) (8), which is mainly expressed in pancreatic islets, the brain, and the gastrointestinal (GI) tract (912), and less prominently in the kidney and eyes (1113)
The trial in people with T2D included 281 participants (mean age 56 years, 56% women, mean BMI 35.0 kg/m 2 , mean HbA1c 8.3%) treated with lifestyle only and/or metformin, with similar intervention arms to the obesity trial, albeit retatrutide 0.5 mg rather than 1 mg, and dulaglutide 1.5 mg was an additional comparator [46]
Because MOTSc is studied in the context of mitochondrial signaling and energysensing biology, it is commonly grouped under longevityfocused research themeswithout implying outcomes outside of a research setting.
Within the components of PN, intravenous fat emulsionsproviding vital medium- and long-chain fatty acidsplay an indispensable role in meeting the high energy demands and supporting the development of premature infants (11)
Overall, the results from this study suggest that the use of GLP-1RAs in the treatment of T2DM may have applications in reducing the risk of CRC in patients who are overweight or obese
